VIEW Lilly gets FDA nod for oral obesity pill, analysts see strong uptake potential

The U.S. Food and Drug Administration has approved Eli Lilly's weight-loss pill, bringing another oral alternatives to a market dominated by injectables and intensifying competition with Novo Nordisk , which sells oral Wegovy.
Open original source